| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,960 |
3,422 |
$176K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
604 |
543 |
$44K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
198 |
183 |
$8K |
| 87428 |
|
327 |
291 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
138 |
132 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
58 |
55 |
$2K |
| 3074F |
|
1,773 |
1,638 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
189 |
176 |
$1K |
| 96127 |
|
143 |
137 |
$475.91 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
493 |
454 |
$286.20 |
| 1160F |
|
2,441 |
2,206 |
$198.00 |
| 1125F |
|
776 |
710 |
$75.00 |
| 1126F |
|
412 |
370 |
$69.00 |
| 3078F |
|
1,235 |
1,143 |
$63.00 |
| 3075F |
|
34 |
24 |
$53.00 |
| 3079F |
|
415 |
360 |
$39.00 |
| 81002 |
|
13 |
13 |
$25.13 |
| 3288F |
|
1,929 |
1,773 |
$0.00 |
| 1159F |
|
1,185 |
1,101 |
$0.00 |
| 3725F |
|
1,357 |
1,253 |
$0.00 |
| 1111F |
|
536 |
447 |
$0.00 |
| 1170F |
|
576 |
511 |
$0.00 |
| 3008F |
|
1,490 |
1,371 |
$0.00 |